Nurix Therapeutics
NRIX
NRIX
68 hedge funds and large institutions have $1.09B invested in Nurix Therapeutics in 2020 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.72% less ownership
Funds ownership: 86% → 85.28% (-0.72%)
2% less capital invested
Capital invested by funds: $1.11B → $1.09B (-$21.9M)
Holders
68
Holding in Top 10
6
Calls
–
Puts
–
Top Buyers
| 1 | +$18.2M | |
| 2 | +$16.4M | |
| 3 | +$11.6M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$10.5M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$8.3M |
Top Sellers
| 1 | -$30.2M | |
| 2 | -$7.76M | |
| 3 | -$4.26M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$4.16M |
| 5 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
-$1.8M |